0
0
0
0
1
2
3
$0
Is Vivmark Residential solid or fragile? The Finex Financial Health Scanner reads VMRK's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $3.1B |
|---|---|
| Net income | $1.1B |
| Operating margin | 28.1% |
| Net margin | 36.2% |
| Cash and investments | $158.9M |
| Total debt | $8.3B |
| Free cash flow | $1.4B |
| Revenue growth (1 year) | 3.8% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.